Biome Australia Ltd (AU:BIO) has released an update.
Biome Australia Ltd has announced a triumphant close to FY24, boasting a remarkable 80% year-over-year growth in unaudited sales revenue, reaching approximately $13 million. This figure surpasses their upgraded forecast by $500k, highlighting a strong financial performance that includes a third consecutive quarter of positive cash flow and a second consecutive quarter of positive EBITDA. The company’s success is underscored by their Activated Probiotics product, which has achieved approximately $12 million in pharmacy retail scans, leading growth in its category.
For further insights into AU:BIO stock, check out TipRanks’ Stock Analysis page.
